KEGG   PATHWAY: umr04520
Entry
umr04520                    Pathway                                
Name
Adherens junction - Ursus maritimus (polar bear)
Description
Cell-cell adherens junctions (AJs), the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. At AJs, E-cadherin serves as an essential cell adhesion molecules (CAMs). The cytoplasmic tail binds beta-catenin, which in turn binds alpha-catenin. Alpha-catenin is associated with F-actin bundles directly and indirectly. The integrity of the cadherin-catenin complex is negatively regulated by phosphorylation of beta-catenin by receptor tyrosine kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which leads to dissociation of the cadherin-catenin complex. Integrity of this complex is positively regulated by beta -catenin phosphorylation by casein kinase II, and dephosphorylation by protein tyrosine phosphatases. Changes in the phosphorylation state of beta-catenin affect cell-cell adhesion, cell migration and the level of signaling beta-catenin. Wnt signaling acts as a positive regulator of beta-catenin by inhibiting beta-catenin degradation, which stabilizes beta-catenin, and causes its accumulation. Cadherin may acts as a negative regulator of signaling beta-catenin as it binds beta-catenin at the cell surface and thereby sequesters it from the nucleus. Nectins also function as CAMs at AJs, but are more highly concentrated at AJs than E-cadherin. Nectins transduce signals through Cdc42 and Rac, which reorganize the actin cytoskeleton, regulate the formation of AJs, and strengthen cell-cell adhesion.
Class
Cellular Processes; Cellular community - eukaryotes
Pathway map
umr04520  Adherens junction
umr04520

Other DBs
GO: 0005912
Organism
Ursus maritimus (polar bear) [GN:umr]
Gene
103656221  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
103656515  PARD3; partitioning defective 3 homolog isoform X1 [KO:K04237]
103656863  RAP1B; ras-related protein Rap-1b [KO:K07836]
103656882  PTPRB; receptor-type tyrosine-protein phosphatase beta isoform X1 [KO:K05694] [EC:3.1.3.48]
103657174  NECTIN2; nectin-2 isoform X1 [KO:K06531]
103657243  RASIP1; ras-interacting protein 1 isoform X1 [KO:K26417]
103657263  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
103657827  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
103657856  MYLPF; myosin regulatory light chain 2, skeletal muscle isoform [KO:K12758]
103658711  KRIT1; krev interaction trapped protein 1 isoform X2 [KO:K17705]
103659146  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
103659169  LMO7; LIM domain only protein 7 [KO:K06084]
103659701  ACP1; low molecular weight phosphotyrosine protein phosphatase isoform X1 [KO:K14394] [EC:3.1.3.2 3.1.3.48]
103659828  [KO:K07836]
103659975  TJP1; tight junction protein ZO-1 isoform X1 [KO:K05701]
103660044  IGF1R; insulin-like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
103660092  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
103660117  ROCK2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
103660204  IQGAP1; ras GTPase-activating-like protein IQGAP1 [KO:K16848]
103660799  AFDN; afadin isoform X1 [KO:K05702]
103661071  ACTN4; alpha-actinin-4 [KO:K05699]
103661279  MYL2; myosin regulatory light chain 2, ventricular/cardiac muscle isoform [KO:K10351]
103661560  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
103661728  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
103662492  NECTIN1; nectin-1 isoform X1 [KO:K06081]
103662651  [KO:K12757]
103662658  [KO:K12757]
103662769  YES1; tyrosine-protein kinase Yes [KO:K05705] [EC:2.7.10.2]
103662806  FARP2; FERM, ARHGEF and pleckstrin domain-containing protein 2 isoform X1 [KO:K06082]
103662842  ROCK1; rho-associated protein kinase 1 isoform X3 [KO:K04514] [EC:2.7.11.1]
103662966  [KO:K06085]
103663384  WAS; wiskott-Aldrich syndrome protein [KO:K05747]
103663779  CTNNA1; catenin alpha-1 isoform X1 [KO:K05691]
103663815  TCF7; transcription factor 7 isoform X1 [KO:K02620]
103664305  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
103664308  WASF3; wiskott-Aldrich syndrome protein family member 3 [KO:K06083]
103664650  PTPRM; receptor-type tyrosine-protein phosphatase mu [KO:K05693] [EC:3.1.3.48]
103665650  SMURF2; E3 ubiquitin-protein ligase SMURF2 [KO:K04678] [EC:2.3.2.26]
103665813  ACTG1; actin, cytoplasmic 2 [KO:K05692]
103665984  BAIAP2; brain-specific angiogenesis inhibitor 1-associated protein 2 isoform X1 [KO:K05627]
103666008  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
103666124  CTNND1; catenin delta-1 isoform X1 [KO:K05690]
103666501  WASF2; wiskott-Aldrich syndrome protein family member 2 [KO:K05748]
103666578  CDC42; cell division control protein 42 homolog [KO:K04393]
103667237  NLK; serine/threonine-protein kinase NLK [KO:K04468] [EC:2.7.11.24]
103667757  CTNNA3; catenin alpha-3 [KO:K05691]
103667838  VCL; vinculin isoform X2 [KO:K05700]
103668810  [KO:K04498] [EC:2.3.1.48]
103669286  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103669358  ARHGAP29; rho GTPase-activating protein 29 [KO:K20644]
103669667  PTPN1; tyrosine-protein phosphatase non-receptor type 1 isoform X1 [KO:K05696] [EC:3.1.3.48]
103669776  SRC; proto-oncogene tyrosine-protein kinase Src [KO:K05704] [EC:2.7.10.2]
103669791  MYL9; myosin regulatory light polypeptide 9 [KO:K12755]
103669836  SNAI1; zinc finger protein SNAI1 [KO:K05707]
103669981  SMURF1; E3 ubiquitin-protein ligase SMURF1 isoform X1 [KO:K04678] [EC:2.3.2.26]
103670081  RADIL; ras-associating and dilute domain-containing protein [KO:K26418]
103670086  ACTB; actin, cytoplasmic 1 [KO:K05692]
103670095  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
103670201  MYL10; myosin regulatory light chain 10 [KO:K12756]
103670905  PTPRF; receptor-type tyrosine-protein phosphatase F [KO:K05695] [EC:3.1.3.48]
103670991  SORBS1; sorbin and SH3 domain-containing protein 1 isoform X1 [KO:K06086]
103671441  CTNNA2; catenin alpha-2 isoform X2 [KO:K05691]
103671448  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
103672110  NECTIN4; nectin-4 [KO:K06593]
103672299  PTPRJ; receptor-type tyrosine-protein phosphatase eta [KO:K05698] [EC:3.1.3.48]
103673623  CDH1; cadherin-1 isoform X1 [KO:K05689]
103673688  CDH5; cadherin-5 [KO:K06533]
103673753  CSNK2A2; casein kinase II subunit alpha' [KO:K03097] [EC:2.7.11.1]
103673974  [KO:K05689]
103674159  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
103674291  ACTN1; alpha-actinin-1 isoform X1 [KO:K05699]
103674361  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
103674660  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
103674678  CCM2; cerebral cavernous malformations 2 protein isoform X1 [KO:K26416]
103674685  MYL7; myosin regulatory light chain 2, atrial isoform [KO:K12754]
103674825  RHOA; transforming protein RhoA [KO:K04513]
103675043  RAP1A; ras-related protein Rap-1A isoform X1 [KO:K04353]
103675777  FER; tyrosine-protein kinase Fer isoform X1 [KO:K08889] [EC:2.7.10.2]
103676308  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]
103676407  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
103676585  MET; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
103676615  WASL; neural Wiskott-Aldrich syndrome protein isoform X1 [KO:K23612]
103676847  MYL5; myosin light chain 5 [KO:K12753]
103676988  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
103677004  WASF1; wiskott-Aldrich syndrome protein family member 1 [KO:K05753]
103677331  NECTIN3; nectin-3 [KO:K06592]
103677415  SNAI2; zinc finger protein SNAI2 [KO:K05706]
103678627  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
103678819  HEG1; LOW QUALITY PROTEIN: protein HEG homolog 1 [KO:K24472]
103679154  SMAD3; mothers against decapentaplegic homolog 3 [KO:K23605]
103680384  CTNNB1; catenin beta-1 [KO:K02105]
103680833  PDCD10; programmed cell death protein 10 [KO:K18269]
103682015  TGFBR2; TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
103682308  CSNK2B; casein kinase II subunit beta [KO:K03115]
Reference
  Authors
Nelson WJ, Nusse R.
  Title
Convergence of Wnt, beta-catenin, and cadherin pathways.
  Journal
Science 303:1483-7 (2004)
DOI:10.1126/science.1094291
Reference
  Authors
Potter E, Bergwitz C, Brabant G.
  Title
The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.
  Journal
Endocr Rev 20:207-39 (1999)
DOI:10.1210/edrv.20.2.0362
Reference
  Authors
Beavon IR.
  Title
The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.
  Journal
Eur J Cancer 36:1607-20 (2000)
DOI:10.1016/S0959-8049(00)00158-1
Reference
  Authors
Reynolds AB, Roczniak-Ferguson A.
  Title
Emerging roles for p120-catenin in cell adhesion and cancer.
  Journal
Oncogene 23:7947-56 (2004)
DOI:10.1038/sj.onc.1208161
Reference
  Authors
Angst BD, Marcozzi C, Magee AI.
  Title
The cadherin superfamily: diversity in form and function.
  Journal
J Cell Sci 114:629-41 (2001)
Reference
  Authors
Lilien J, Balsamo J, Arregui C, Xu G.
  Title
Turn-off, drop-out: functional state switching of cadherins.
  Journal
Dev Dyn 224:18-29 (2002)
DOI:10.1002/dvdy.10087
Reference
  Authors
Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M.
  Title
p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.
  Journal
Mol Cell Biol 23:2287-97 (2003)
DOI:10.1128/MCB.23.7.2287-2297.2003
Reference
  Authors
Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A.
  Title
Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.
  Journal
J Cell Biol 163:847-57 (2003)
DOI:10.1083/jcb.200308162
Reference
  Authors
Ciruna B, Rossant J.
  Title
FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak.
  Journal
Dev Cell 1:37-49 (2001)
DOI:10.1016/S1534-5807(01)00017-X
Reference
  Authors
Peinado H, Quintanilla M, Cano A.
  Title
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.
  Journal
J Biol Chem 278:21113-23 (2003)
DOI:10.1074/jbc.M211304200
Reference
  Authors
Labbe E, Letamendia A, Attisano L.
  Title
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
  Journal
Proc Natl Acad Sci U S A 97:8358-63 (2000)
DOI:10.1073/pnas.150152697
Reference
  Authors
Nakanishi H, Takai Y.
  Title
Roles of nectins in cell adhesion, migration and polarization.
  Journal
Biol Chem 385:885-92 (2004)
DOI:10.1515/BC.2004.116
Reference
  Authors
Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.
  Title
Roles and modes of action of nectins in cell-cell adhesion.
  Journal
Semin Cell Dev Biol 15:643-56 (2004)
DOI:10.1016/j.semcdb.2004.09.002
Related
pathway
umr04010  MAPK signaling pathway
umr04060  Cytokine-cytokine receptor interaction
umr04310  Wnt signaling pathway
umr04350  TGF-beta signaling pathway
umr04530  Tight junction
umr04810  Regulation of actin cytoskeleton
KO pathway
ko04520   

DBGET integrated database retrieval system